Daesung Microbiological Labs. Co. Ltd (036480) — Cash Flow-to-Debt Ratio
Daesung Microbiological Labs. Co. Ltd (036480) has a Cash Flow-to-Debt Ratio of 0.04x as of December 2025, meaning its operating cash flow of ₩972.26 Million could theoretically repay 0% of its total liabilities (₩22.56 Billion) in one year. Explore 036480 long-term investments to assets to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Daesung Microbiological Labs. Co. Ltd Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Daesung Microbiological Labs. Co. Ltd across 14 annual periods. Also explore how large is Daesung Microbiological Labs. Co. Ltd's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Daesung Microbiological Labs. Co. Ltd (2012–2025)
Year-by-year debt coverage analysis for Daesung Microbiological Labs. Co. Ltd. For market capitalisation and broader financial context, see how much is Daesung Microbiological Labs. Co. Ltd worth.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.06x | ₩1.41 Billion | ₩22.56 Billion | ▼ -31.0% |
| 2024 | 0.09x | ₩2.10 Billion | ₩23.23 Billion | ▲ +297.7% |
| 2023 | -0.05x | ₩-1.23 Billion | ₩26.94 Billion | ▼ -204.1% |
| 2022 | 0.04x | ₩1.16 Billion | ₩26.27 Billion | ▼ -48.9% |
| 2021 | 0.09x | ₩2.20 Billion | ₩25.62 Billion | ▼ -31.0% |
| 2020 | 0.12x | ₩3.24 Billion | ₩25.95 Billion | ▼ -15.6% |
| 2019 | 0.15x | ₩2.32 Billion | ₩15.68 Billion | ▼ -76.0% |
| 2018 | 0.62x | ₩3.14 Billion | ₩5.09 Billion | ▲ +64.5% |
| 2017 | 0.37x | ₩1.68 Billion | ₩4.49 Billion | ▼ -29.8% |
| 2016 | 0.53x | ₩3.52 Billion | ₩6.60 Billion | ▼ -49.0% |
| 2015 | 1.05x | ₩7.66 Billion | ₩7.33 Billion | ▲ +81.5% |
| 2014 | 0.58x | ₩3.83 Billion | ₩6.65 Billion | ▲ +181.4% |
| 2013 | 0.20x | ₩1.89 Billion | ₩9.23 Billion | ▼ -49.4% |
| 2012 | 0.40x | ₩2.33 Billion | ₩5.76 Billion | — |